课题基金 / 基金详情

Identification of predictive factors of adjuvant chemotherapy for breast cancer

Identification of predictive factors of adjuvant chemotherapy for breast cancer
乳腺癌辅助化疗预测因素的鉴定
批准号:
20591546
负责人:
TAIRA Naruto
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Background : Taxanes are important drugs in treatment of breast cancer. These drugs bind to tubulin and suppress spindle microtubule dynamics, which leads to cell cycle arrest in the G2/M phase followed by apoptosis. However, resistance to taxane therapy prevents some patients from benefiting from these drugs. Several mechanisms of taxane resistance have been described, including the involvement of microtubule-associated protein-tau (MAPT). MAPT binds to the same pocket as taxanes in microtubules and obstructs the function of the drug. Estrogen receptors (ER) are transcriptional factors that play an important role in the development and progression of breast cancer. However, the relationship between ER and MAPT in breast cancer is not entirely clear. In this study we examined the correlation between MAPT expression and the sensitivity of human breast cancer cells to taxanes, and the relationship between ER and MAPT at the protein level in these cells. We also examined combination thera … More py with hormone drugs and taxanes. Methods : The correlation between MAPT expression and sensitivity to taxanes was examined in 12 human breast cancer cell lines using real time PCR, western blotting analysis and an MTS assay. Following small interfering RNA (siRNA) knockdown of MAPT expression, the alteration of cellular sensitivity to taxanes was examined by MTS assay, flow cytometry and immunofluorescence. To examine the relationship between ER and MAPT, ER expression was knocked down with siRNA or stimulated with 17-β-estradiol in MAPT- and ER-positive cell lines (MCF-7 and ZR75.1, respectively). The cells were also treated with hormone drugs (tamoxifen and ICI182,780) and changes in MAPT protein expression were examined. Results : Six cell lines showed high MAPT mRNA expression and four showed high MAPT protein expression ; that is, expression at the mRNA level did not always correlate with that at the protein level. MAPT mRNA expression did not correlate with taxane resistance, but expression of MAPT protein isoforms under 70kDa correlated with taxane resistance. Downregulation of MAPT increased sensitivity to taxanes. MAPT protein expression was decreased by ER knockdown and increased by 17-β-estradiol stimulation. The MAPT protein level was also increased by tamoxifen, but decreased by IC1182,780. Combination treatment of taxanes with ICI182,780 showed a strong synergistic effect, but similar treatment with tamoxifen had an antagonistic effect in both cell lines. Conclusions : Expression of MAPT protein isoforms under 70kDa correlates with taxane resistance in breast cancer cells. MAPT expression is influenced by ER in breast cancer and ICI182,780, a selective ER inhibitor, can reverse the resistance to taxanes in both MAPT- and ER-positive breast cancer. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1186/bcr2598
发表时间: 2010-01-01
期刊: BREAST CANCER RESEARCH
影响因子: 7.4
作者: [Ikeda, Hirokuni, Taira, Naruto, Miyoshi, Shinichiro]
通讯作者: Miyoshi, Shinichiro
乳癌細胞株におけるmicorotubule assosiated protein-tau (MAPT)についての検討
乳腺癌细胞系中微管相关蛋白 tau (MAPT) 的研究
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [池田宏国, 平成人, 他]
通讯作者:
ERシグナル遮断により化学療法剤の感受性は増加するのか-in vivo and vitro study-
ER信号阻断是否会增加对化疗药物的敏感性 - 体内和体外研究 -
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [池田宏国, 平成人, 他]
通讯作者:
Microtubule associated protein-tau (MAPT) is influenced by ER : ICI182,780, a selective ER inhibitor, down-regulates MAPT expression and reverses resistance to taxanes in MAPT- and ER-positive breast cancer cells.
微管相关蛋白 tau (MAPT) 受 ER 影响:ICI182,780 是一种选择性 ER 抑制剂,可下调 MAPT 表达并逆转 MAPT 和 ER 阳性乳腺癌细胞对紫杉烷的耐药性。
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [池田宏国, 平成人, 他]
通讯作者:
6
    海外基金